GeNeuro Innovation SAS
7 clinical trials · Sponsor
◉ Watch GeNeuro Innovation SAS
| Record | Firm | Date |
|---|---|---|
| A Long-term Extension of Study GNC-401 (NCT05049161) | GeNeuro Innovation SAS | 2021-08-27 |
| Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (NCT04480307) | GeNeuro Innovation SAS | 2020-06-17 |
Track GeNeuro Innovation SAS automatically
Every clearance here is in the API, with alerts when new ones post.